The Possible Efficacy and Safety of L-carnitine and Biotin as Adjunctive Therapies in Children With Moderate Persistent Asthma

Conditions: Moderate Persistent Asthma

Sex: All

Ages: 8 Years – 18 Years

Phase: PHASE3

Enrollment: 66

Sponsor: Tanta University

Location: Egypt

Summary

The Possible Efficacy and Safety of L-carnitine and Biotin as Adjunctive Therapies in Children with Moderate Persistent Asthma

Eligibility Criteria

Inclusion Criteria:Children with moderate persistent asthmaAge range of 8-< 18 years oldBoth sexExclusion Criteria:Children with any pulmonary or chronic systemic diseases other than asthma (cystic fibrosis, bronchiectasis, tuberculosis, diabetes mellitus, and liver disease).Children with immunodeficiency.Children with thyroid disorder.Children with recent infection (especially pneumonia), surgery, anesthesia.Children having clinical evidence of any heart renal and hepatic diseases.Children having cystic fibrosis or congenital respiratory disease.Children having chronic diarrhea and mal-absorption.Children having clinical evidence of malnutrition.Children on medications that could interfere with L-carnitine level including antibiotics use. (particularly ampicillins) and anti- convulsing particularly valoproic acid.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05632549). StuddyBuddy aggregates publicly available trial information.